ArticleMammalian genome : official journal of the International Mammalian Genome Society2026
Tissue-specific transcriptional epistasis between Prkn and Lrrk2 during mycobacterial infection.
Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
PRKN (PARK2) and LRRK2 are susceptibility genes for Parkinson’s disease that also exert pleiotropic effects in inflammatory and mycobacterial diseases. Although each gene individually regulates innate immune pathways, their combined in vivo interaction during infection remains undefined. We hypothesized that Prkn and Lrrk2 exhibit systems-level epistasis in shaping host transcriptional responses to mycobacterial challenge. To test this, we analyzed single and double knockout mice to define baseline and infection-induced transcriptional programs following bacille Calmette-Guérin (BCG) infection. Lung and spleen tissues were assessed for bacterial burden and genome-wide gene expression. In the lung, deletion of Prkn and Lrrk2 affected overlapping immune pathways, and double knockout mice displayed non-additive modulation of infection-induced transcriptional networks, consistent with systems-level epistasis. In contrast, splenic responses were dominated by Lrrk2 deletion, indicating tissue-dependent genetic interaction. To determine whether these transcriptional effects extended to virulent mycobacteria, we examined Lrrk2-dependent responses during aerosol infection with Mycobacterium tuberculosis, revealing context-dependent pathway activation distinct from the BCG model. These findings demonstrate tissue- and pathogen-specific epistasis between Prkn and Lrrk2 at the level of host transcriptional network organization. Our results establish these genes as interacting regulators of antimycobacterial immune programs and provide a systems-genetic framework linking neurodegeneration-associated loci to host defense.
Indexed as
Identifiers
41920332What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.